Skip to main content
. 2015 Aug 10;112(34):E4707–E4716. doi: 10.1073/pnas.1506749112

Table S1.

Sequences and molecular masses of tryptic peptides from ribosomal proteins and RlmE used for SILAC analyses

Ribosomal protein Peptides m/z
Sequence Position Mass, Da z Nonlabeled Labeled
L3 NLLLVK 185–190 698.47 1 699.48 707.50
AIQVTTGAK 47–55 887.51 2 444.76 448.77
VDVTGTSK 107–114 805.42 2 403.72 407.73
L5 LHDYYK 4–9 837.40 1 838.41 846.43
SVAGFK 73–78 607.33 1 608.34 616.36
GLSAK 116–120 474.28 1 475.29 483.30
L6 APVVVPAGVDVK 7–18 1,149.68 2 575.85 579.85
INGQVITIK 19–27 984.60 2 493.31 497.31
TLNDAVEVK 36–44 987.52 2 494.77 498.78
L7/12 DLVESAPAALK 86–96 1,112.61 2 557.31 561.32
ALEEAGAEVEVK 110–121 1,243.63 2 622.82 626.83
DDAEALK 102–108 760.36 1 761.37 769.38
L9 RAELEAK 51–57 815.45 2 408.73 412.74
NFLVPQGK 28–35 901.52 1 902.51 910.53
VANLGSLGDQVNVK 9–22 1,412.76 2 707.39 711.40
L10 ALNLQDK 2–8 800.44 2 401.23 405.23
QAIVAEVSEVAK 9–20 1,242.68 2 622.35 626.36
GVTVDK 32–37 617.34 1 618.35 626.36
L11 SFTFVTK 66–72 828.44 1 829.45 837.46
AQLQEIAQTK 104–113 1,128.61 2 565.32 569.33
TPPAAVLLK 73–81 908.57 2 455.29 459.30
L13 DWYVVDATGK 14–23 1,152.55 2 577.28 581.29
VYYHHTGHIGGIK 73–85 1,480.76 2 741.39 745.40
VIEIAVK 100–106 770.49 2 386.25 390.26
L14 YAGVGDIIK 32–40 934.51 1 935.53 943.54
GDVLK 55–59 530.31 1 531.32 539.33
KGDVLK 54–59 658.40 1 659.41 675.44
L15 LNTLSPAEGSK 3–13 1,115.58 2 558.80 562.81
AAIEAAGGK 133–141 786.42 2 394.22 398.23
GIGSGLGK 22–29 687.39 1 688.40 696.41
L16 GLAQGTDVSFGSFGLK 19–34 1,582.80 2 792.41 796.41
GNVEYWVALIQPGK 87–100 1,572.83 2 787.42 791.43
TTFVTK 128–133 695.39 1 696.39 704.41
L17 VVEPLTITLAK 47–57 1,182.72 2 541.85 545.85
TRDNEIVAK 70–78 1,044.56 2 523.78 527.74
DNEIVAK 72–78 787.41 1 788.42 796.43
L18 DAAAAVGK 69–76 701.37 1 702.38 710.39
AIAEQLK 57–63 771.45 2 386.73 390.74
KLQELGATR 17–25 1,014.58 2 508.30 512.31
L19 SNIIK 2–6 573.35 1 574.36 582.37
VWVVEGSK 30–37 902.49 1 903.50 911.51
QLEQEQMK 7–14 1,032.49 2 517.25 521.26
L20 FINGLK 79–84 690.41 1 692.40 700.41
VAFTALVEK 104–112 976.56 1 977.57 985.59
QNGISYSK 71–78 895.44 2 449.22 453.23
L21 MYAVFQSGGK 1–10 1,086.52 2 544.27 548.27
IGVPFVDGGVIK 49–60 1,199.69 2 600.85 604.86
QWFTDVK 91–97 922.45 2 462.24 466.24
L22 AAVLVK 43–48 599.40 1 600.41 608.42
IFVDEGPSMK 74–83 1,121.54 2 561.78 565.79
KAAVLVK 42–48 727.50 1 728.50 744.53
L23 SNTIVLK 27–33 773.46 2 387.74 391.75
DATKAEIK 37–44 874.48 2 438.25 446.27
APHVSEK 13–19 766.40 2 384.21 388.21
L24 DDEVIVLTGK 8–17 1,087.58 2 544.80 548.80
NVLSSGK 27–33 703.39 1 704.40 712.41
VIVEGINLVK 34–43 1,082.67 2 542.34 546.35
L25 EAPLAIELDHDK 35–46 1,349.68 2 675.85 679.86
FPAIIYGGK 26–34 964.54 2 483.27 487.28
VMNMQAK 47–53 820.39 2 411.20 415.21
L27 DHTLFAK 56–62 830.43 2 416.22 420.23
L28 SHALNATK 19–26 840.45 2 421.23 425.24
FWVESEK 38–44 923.44 2 462.73 466.74
ARGEKY 73–78 722.37 2 362.19 366.20
L34 LTVSK 42–46 546.34 1 547.35 555.36
L35 HILTK 31–35 610.38 1 611.39 619.40
RlmE LDEIQQSDK 39–47 1,074.52 2 538.27 542.28
DVLAPGGSFVVK 153–164 1,187.66 2 594.83 598.84
VRKPDSSR 187–194 943.52 2 472.77 476.78
HHS Vulnerability Disclosure